insights_auto
Why is ANW down 33,90%?
Dive Deeperchevron_right
ANW:FRA
Immuron Ltd
€0,020
arrow_downward
-33,90%(-0,010) 1D
13 ຕ.ລ., 8 ໂມງ 6 ນາທີ 21 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ANW...
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
12,20 ລ້ານ
Avg. vol.
627,00
Volume
0,00
52-wk high
€0,04
52-wk low
€0,01
No. of employees
8
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
12,20 ລ້ານ
Avg. vol.
627,00
Volume
0,00
52-wk high
€0,04
52-wk low
€0,01
No. of employees
8
News stories
From web sources and news partners
TipRanks
·
8 ຊົ່ວໂມງກ່ອນ
Immuron advances Travelan after Phase 2 data published in Nature journal
https://www.dars.gov.et/
·
1 ອາທິດກ່ອນ
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - MA Cross Alert
Profile
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
About Immuron Ltd
CEO-
Employees8
Founded1994
HeadquartersBlackburn North, Victoria, ອອສເຕຣເລຍ
SectorBiotechnology
Websiteimmuron.com.au